Vivimed Labs Financials
NSE: VIVIMEDLAB | BSE: 532660
₹6.58
As on 04-Sep-2026 15:54IST
Market cap
₹55 Cr
Revenue (TTM)
₹70 Cr
P/E Ratio
--
P/B Ratio
-0.2
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
69.99
|
116.27
|
149.07
|
187.10
|
237.29
|
861.47
|
|||||
|
Total Income
|
76.33
|
120.64
|
159.05
|
188.07
|
238.56
|
871.29
|
|||||
|
Total Expenditure
|
222.43
|
129.28
|
181.95
|
374.09
|
245.11
|
829.59
|
|||||
|
EBITDA
|
-152.44
|
-13.01
|
-32.87
|
-186.99
|
-7.83
|
31.88
|
|||||
|
Depreciation
|
26.05
|
20.23
|
19.94
|
108.41
|
18.28
|
55.50
|
|||||
|
EBIT
|
-178.49
|
-33.24
|
-52.82
|
-295.39
|
-26.11
|
-23.62
|
|||||
|
Interest
|
4.18
|
2.98
|
2.98
|
36.23
|
39.99
|
56.06
|
|||||
|
Other Income
|
6.34
|
4.37
|
9.98
|
0.97
|
1.27
|
9.82
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-176.33
|
-31.85
|
-45.82
|
-330.65
|
-64.83
|
-69.86
|
|||||
|
Provision for Tax
|
0.14
|
0.11
|
-0.38
|
-2.12
|
2.82
|
2.03
|
|||||
|
Profit after Tax
|
-176.47
|
-31.96
|
-45.45
|
-328.54
|
-67.65
|
-71.89
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
-176.47
|
-31.96
|
-45.45
|
-328.54
|
-67.65
|
-71.89
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-210.55
|
-35.17
|
-5.46
|
39.42
|
364.29
|
431.58
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
515.92
|
547.81
|
545.61
|
531.54
|
528.34
|
516.68
|
|||||
|
Current Liabilities
|
448.11
|
408.21
|
410.71
|
424.25
|
373.39
|
341.08
|
|||||
|
Total Liabilities
|
753.48
|
920.85
|
950.86
|
995.21
|
1,266.01
|
1,289.33
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
583.95
|
593.28
|
607.89
|
656.06
|
758.75
|
760.62
|
|||||
|
Current Assets
|
168.00
|
327.57
|
342.97
|
339.14
|
507.27
|
528.71
|
|||||
|
Total Assets
|
753.48
|
920.85
|
950.86
|
995.21
|
1,266.01
|
1,289.33
|
|||||
|
Total Debt*
|
--
|
376.33
|
376.93
|
378.57
|
358.88
|
325.62
|
|||||
|
Net Current Assets
|
-280.11
|
-80.64
|
-67.74
|
-85.10
|
133.88
|
187.63
|
|||||
|
Contingent Liabilities
|
--
|
182.90
|
115.79
|
122.93
|
215.57
|
220.66
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-1.75
|
-23.99
|
35.32
|
27.54
|
567.28
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-4.53
|
28.29
|
-4.97
|
-16.41
|
404.00
|
|||||
|
Cash from Financing Activities
|
--
|
4.96
|
-6.03
|
-33.78
|
-10.38
|
-1,015.33
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-1.32
|
-1.74
|
-3.42
|
0.75
|
-44.06
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-21.28
|
-3.85
|
-5.48
|
-39.62
|
-8.16
|
-8.67
|
|||||
|
Cash EPS (₹)
|
-21.28
|
-1.42
|
-3.08
|
-26.55
|
-5.95
|
-1.98
|
|||||
|
Adjusted Book Value (₹)
|
-30.11
|
-8.82
|
-5.24
|
0.17
|
39.35
|
47.47
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
-0.21
|
-2.89
|
4.26
|
3.32
|
68.42
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-1.16
|
-3.38
|
-0.41
|
-3.86
|
59.36
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-9.07
|
-12.01
|
-55.28
|
-3.54
|
-1.12
|
|||||
|
ROE (%)
|
--
|
--
|
--
|
-200.51
|
-18.80
|
-16.62
|
|||||
|
ROA (%)
|
-21.08
|
-3.42
|
-4.67
|
-29.06
|
-5.29
|
-4.13
|
|||||
|
EBIT Margin (%)
|
-255.02
|
-28.59
|
-35.43
|
-157.88
|
-11.00
|
-2.74
|
|||||
|
Net Margin (%)
|
-231.21
|
-26.49
|
-28.57
|
-174.69
|
-28.36
|
-8.25
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
-10.09
|
-17.11
|
-117.65
|
-20.80
|
-1.90
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-39.80
|
-22.00
|
-20.33
|
-21.15
|
-72.46
|
-18.64
|
|||||
|
EBIT Growth (%)
|
-436.45
|
37.07
|
82.12
|
-1,031.34
|
-10.56
|
60.90
|
|||||
|
Net Profit Growth (%)
|
-452.15
|
29.67
|
86.17
|
-385.64
|
5.89
|
34.12
|
|||||
|
EPS Growth (%)
|
-452.15
|
29.67
|
86.17
|
-385.64
|
5.89
|
34.12
|
|||||
|
Book Value Growth (%)
|
--
|
-68.36
|
-3,156.33
|
-99.56
|
-17.10
|
-16.50
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-0.31
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
-0.22
|
--
|
--
|
38.89
|
0.37
|
0.33
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-3.09
|
-45.38
|
-17.10
|
-2.31
|
-71.91
|
10.81
|
|||||
|
Close Price (₹)
|
5.28
|
--
|
--
|
6.60
|
14.50
|
16.10
|
|||||
|
High Price (₹)
|
29.40
|
--
|
--
|
17.40
|
41.50
|
23.62
|
|||||
|
Low Price (₹)
|
5.26
|
--
|
--
|
6.60
|
14.25
|
7.25
|
|||||
|
Market Cap (₹ Cr)
|
55.30
|
--
|
--
|
55.31
|
119.81
|
131.46
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
-0.34
|
-5.14
|
-8.67
|
266.22
|
1.10
|
0.83
|
|||||
|
Short term debt to equity ratio
|
--
|
-8.89
|
-57.38
|
5.70
|
0.60
|
0.45
|
|||||
|
Current Ratio
|
0.37
|
0.80
|
0.84
|
0.80
|
1.36
|
1.55
|
|||||
|
Quick Ratio
|
0.35
|
0.66
|
0.68
|
0.61
|
0.71
|
0.80
|
|||||
|
Interest Coverage
|
-41.16
|
-9.69
|
-14.36
|
-8.13
|
-0.62
|
-0.25
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
64.77
|
63.74
|
55.56
|
39.63
|
36.82
|
12.48
|
|||||
|
Asset Turnover
|
0.08
|
0.12
|
0.15
|
0.17
|
0.19
|
0.49
|
|||||
|
Receivable days
|
--
|
246.32
|
192.18
|
157.55
|
149.87
|
75.54
|
|||||
|
Inventory Days
|
--
|
192.78
|
176.07
|
312.65
|
381.82
|
160.49
|
|||||
|
Payable days
|
--
|
254.58
|
253.55
|
65.28
|
90.54
|
134.23
|
|||||
|
Cash Conversion Cycle
|
--
|
184.52
|
114.70
|
404.91
|
441.16
|
101.80
|